Advances in the 5q- syndrome.

Advances in the 5q- syndrome.

The 5q- syndrome is the most distinct of all the myelodysplastic syndromes with a clear genotype/phenotype relationship. The significant progress made during recent years has been based on the determination of the commonly deleted region and the demonstration of haploinsufficiency for the ribosomal...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Boultwood, J, Pellagatti, A, McKenzie, A, Wainscoat, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2010

Gelijkaardige items

5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2012)

RECENT ADVANCES IN THE 5Q- SYNDROME
door: Andrea Pellagatti, et al.
Gepubliceerd in: (2015-05-01)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2012)

The 5q-syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1994)

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.
door: Pellagatti, A, et al.
Gepubliceerd in: (2010)

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
door: Boultwood, J, et al.
Gepubliceerd in: (2013)

The 5q- syndrome.
door: Giagounidis, A, et al.
Gepubliceerd in: (2004)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
door: Pellagatti, A, et al.
Gepubliceerd in: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
door: Pellagatti, A, et al.
Gepubliceerd in: (2011)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
door: Pellagatti, A, et al.
Gepubliceerd in: (2003)

MOLECULAR DELINEATION OF THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
door: Boultwood, J, et al.
Gepubliceerd in: (1993)

The human POP2 gene: identification, sequencing, and mapping to the critical region of the 5q- syndrome.
door: Fidler, C, et al.
Gepubliceerd in: (1999)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
door: Pellagatti, A, et al.
Gepubliceerd in: (2005)

Gene expression profiling in the myelodysplastic syndromes.
door: Pellagatti, A, et al.
Gepubliceerd in: (2005)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
door: Jadersten, M, et al.
Gepubliceerd in: (2005)

Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
door: Boultwood, J, et al.
Gepubliceerd in: (1994)

MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT
door: Boultwood, J, et al.
Gepubliceerd in: (1993)

Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
door: Yip, B, et al.
Gepubliceerd in: (2012)

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
door: Yip, B, et al.
Gepubliceerd in: (2012)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).
door: Pellagatti, A, et al.
Gepubliceerd in: (2004)

SF3B1 mutant myelodysplastic syndrome: Recent advances
door: Pellagatti, A, et al.
Gepubliceerd in: (2020)

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression.
door: Jädersten, M, et al.
Gepubliceerd in: (2009)

ISOLATION OF NOVEL CDNA CLONES MAPPING TO THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
door: Boultwood, J, et al.
Gepubliceerd in: (1994)

Homozygous deletion of FMS in a patient with the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1990)

Narrowing and genomic annotation of the critical region of the 5q-syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2000)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2007)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
door: Pellagatti, A, et al.
Gepubliceerd in: (2008)

Physical mapping of the human ATX1 homologue (HAH1) to the critical region of the 5q- syndrome within 5q32, and immediately adjacent to the SPARC gene.
door: Boultwood, J, et al.
Gepubliceerd in: (2000)

Molecular analysis of the 5q-syndrome
door: Boultwood, J
Gepubliceerd in: (2007)

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.
door: Barlow, J, et al.
Gepubliceerd in: (2010)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
door: Fernandez-Mercado, M, et al.
Gepubliceerd in: (2013)

Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.
door: Jaju, R, et al.
Gepubliceerd in: (2000)

Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
door: Yip, B, et al.
Gepubliceerd in: (2013)

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression
door: Martin Jädersten, et al.
Gepubliceerd in: (2009-12-01)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
door: Fidler, C, et al.
Gepubliceerd in: (2004)

Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
door: Yip, B, et al.
Gepubliceerd in: (2013)

Lenalidomide up-regulates SPARC and inhibits in vitro growth of the malignant clone in myelodysplastic syndrome patients with 5q deletion.
door: Pellagatti, A, et al.
Gepubliceerd in: (2006)

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (1993)

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome.
door: Boultwood, J, et al.
Gepubliceerd in: (2002)

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
door: Pellagatti, A, et al.
Gepubliceerd in: (2007)